REYVOW (lasmiditan succinate) Eli lilly and co Patent: 8,748,459 Expiration: Mar 27, 2023 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,…
The post Drug Patent Expirations for the Week of March 26, 2023 appeared first on DrugPatentWatch - Make Better Decisions.